$MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock $mrvi

$mrvi Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000182323924000032 Filed on February 29, 2024

Income Statement

Concept	2023 Q4	2023	2022
Revenue	$74.14M	$288.9M	$883.0M
YoY Change	-63.78%	-67.28%	10.48%
Cost Of Revenue	$35.11M	$148.7M	$169.0M
YoY Change	-34.07%	-11.96%	20.2%
Gross Profit	$39.03M	$140.2M	$714.0M
YoY Change	-74.23%	-80.37%	8.41%
Gross Profit Margin	52.65%	48.52%	80.87%
Selling, General & Admin	$38.48M	$151.4M	$129.3M
YoY Change	3.43%	17.12%	29.18%
% of Gross Profit	98.58%	107.98%	18.1%
Research & Development	$4.594M	$17.28M	$18.37M
YoY Change	4.15%	-5.93%	20.7%
% of Gross Profit	11.77%	12.33%	2.57%
Depreciation & Amortization	$10.80M	$12.90M	$7.566M
YoY Change	31.75%	70.47%	17.98%
% of Gross Profit	27.67%	9.2%	1.06%
Operating Expenses	$39.72M	$168.7M	$147.6M
YoY Change	-5.92%	14.25%	28.06%
Operating Profit	-$684.0K	-$31.65M	$574.2M
YoY Change	-100.63%	-105.51%	3.53%
Interest Expense	-$7.941M	$45.89M	$20.41M
YoY Change	1.26%	124.81%	-32.54%
% of Operating Profit			3.56%
Other Income/Expense, Net	$671.3M	-$1.337M	-$358.0K
YoY Change	-12243.22%	273.46%	-228.32%
Pretax Income	$656.2M	$617.7M	$551.5M
YoY Change	584.41%	12.02%	3.9%
Income Tax	$766.2M	$756.1M	$60.81M
% Of Pretax Income	116.76%	122.4%	11.03%
Net Earnings	-$106.0M	-$119.0M	$220.2M
YoY Change	-381.55%	-154.05%	20.97%
Net Earnings / Revenue	-142.92%	-41.19%	24.94%
Basic Earnings Per Share		-$0.90	$1.67
Diluted Earnings Per Share	-$0.80	-$0.90	$1.67
COMMON SHARES
Basic Shares Outstanding		131.9M shares	131.5M shares
Diluted Shares Outstanding		131.9M shares	255.3M shares

Balance Sheet

Concept	2023 Q4	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$575.0M	$575.0M	$632.1M
YoY Change	-9.04%	-9.04%	14.67%
Cash & Equivalents	$575.0M
Short-Term Investments
Other Short-Term Assets	$17.83M	$17.83M	$25.80M
YoY Change	-30.89%	-30.89%	30.97%
Inventory	$51.40M	$51.40M	$43.15M
Prepaid Expenses
Receivables	$54.61M	$54.61M	$138.6M
Other Receivables	$1.118M	$1.118M	$8.190M
Total Short-Term Assets	$699.9M	$699.9M	$847.9M
YoY Change	-17.45%	-17.45%	14.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$162.9M	$222.6M	$116.6M
YoY Change	209.14%	90.96%	22.18%
Goodwill	$326.0M
YoY Change	14.93%
Intangibles	$221.0M
YoY Change	2.0%
Long-Term Investments
YoY Change
Other Assets	$77.62M	$17.88M	$817.5M
YoY Change	-32.85%	-97.81%	0.62%
Total Long-Term Assets	$787.5M	$787.5M	$1.434B
YoY Change	-45.1%	-45.1%	21.74%
TOTAL ASSETS
Total Short-Term Assets	$699.9M	$699.9M	$847.9M
Total Long-Term Assets	$787.5M	$787.5M	$1.434B
Total Assets	$1.487B	$1.487B	$2.282B
YoY Change	-34.83%	-34.83%	18.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.73M	$10.73M	$5.991M
YoY Change	79.09%	79.09%	-26.53%
Accrued Expenses	$60.24M	$56.58M	$50.63M
YoY Change	12.86%	11.76%	72.56%
Deferred Revenue	$3.360M
YoY Change	8.81%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.440M	$6.073M	$5.440M
YoY Change	0.0%	11.64%	-9.33%
Total Short-Term Liabilities	$87.47M	$87.47M	$110.1M
YoY Change	-20.59%	-20.59%	17.45%
LONG-TERM LIABILITIES
Long-Term Debt	$518.7M	$550.6M	$522.0M
YoY Change	-0.63%	5.48%	-0.49%
Other Long-Term Liabilities	$59.49M	$59.49M	$744.9M
YoY Change	-13.75%	-92.01%	-1.27%
Total Long-Term Liabilities	$578.2M	$610.1M	$1.267B
YoY Change	-2.16%	-51.84%	-0.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$87.47M	$87.47M	$110.1M
Total Long-Term Liabilities	$578.2M	$610.1M	$1.267B
Total Liabilities	$697.6M	$1.071B	$1.737B
YoY Change	-49.34%	-38.36%	8.38%
SHAREHOLDERS EQUITY
Retained Earnings	$285.7M
YoY Change	-29.41%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$416.8M	$416.8M	$545.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.487B	$1.487B	$2.282B
YoY Change	-34.83%	-34.83%	18.98%

Cashflow Statement

Concept	2023 Q4	2023	2022
OPERATING ACTIVITIES
Net Income	-$106.0M	-$119.0M	$220.2M
YoY Change	-381.55%	-154.05%	20.97%
Depreciation, Depletion And Amortization	$10.80M	$12.90M	$7.566M
YoY Change	31.75%	70.47%	17.98%
Cash From Operating Activities	$7.790M	$126.2M	$536.0M
YoY Change	-92.16%	-76.45%	45.42%
INVESTING ACTIVITIES
Capital Expenditures	$16.80M	$65.55M	$17.09M
YoY Change	170.34%	283.58%	15.08%
Acquisitions		$69.62M	$239.0M
YoY Change		-70.87%
Other Investing Activities	$3.896M	-$56.76M	-$250.5M
YoY Change	-131.66%	-77.34%	-307.89%
Cash From Investing Activities	-$12.90M	-$122.3M	-$267.6M
YoY Change	-30.33%	-54.3%	-353.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net		$5.440M	$13.90M
YoY Change		-60.85%	131.58%
Cash From Financing Activities	470.0K	-$61.09M	-$187.5M
YoY Change	-100.71%	-67.42%	17.89%
NET CHANGE
Cash From Operating Activities	7.790M	$126.2M	$536.0M
Cash From Investing Activities	-12.90M	-$122.3M	-$267.6M
Cash From Financing Activities	470.0K	-$61.09M	-$187.5M
Net Change In Cash	-4.643M	-$57.18M	$80.87M
YoY Change	-131.6%	-170.7%	-74.34%
FREE CASH FLOW
Cash From Operating Activities	$7.790M	$126.2M	$536.0M
Capital Expenditures	$16.80M	$65.55M	$17.09M
Free Cash Flow	-$9.009M	$60.67M	$518.9M
YoY Change	-109.67%	-88.31%	46.69%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	617736000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	756111000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	60809000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	490663000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	469250000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	676000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	8503000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3457000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	250000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-15978000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	287213000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001823239
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2020	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201602Member
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39725
CY2023	dei	Entity Registrant Name EntityRegistrantName	Maravai LifeSciences Holdings, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2786970
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	10770 Wateridge Circle
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92121
CY2023	dei	City Area Code CityAreaCode	858
CY2023	dei	Local Phone Number LocalPhoneNumber	546-0004
CY2023	dei	Security12b Title Security12bTitle	Class A common stock, $0.01 par value
CY2023	dei	Trading Symbol TradingSymbol	MRVI
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	1370000000	usd
CY2023	dei	Auditor Firm AuditorFirmId	42
CY2023	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2023	dei	Auditor Location AuditorLocation	San Mateo, California
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	574962000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	632138000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	54605000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	138624000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	51397000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	43152000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17830000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	25798000	usd
CY2023Q4	us-gaap	Government Assistance Amount Cumulative Current GovernmentAssistanceAmountCumulativeCurrent	1118000	usd
CY2022Q4	us-gaap	Government Assistance Amount Cumulative Current GovernmentAssistanceAmountCumulativeCurrent	8190000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	699912000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	847902000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	162900000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	52694000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	326029000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	283668000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	220987000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	216663000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	765799000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	77622000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	115589000	usd
CY2023Q4	us-gaap	Assets Assets	1487450000	usd
CY2022Q4	us-gaap	Assets Assets	2282315000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60237000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	53371000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3360000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3088000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5440000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5440000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	633000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	87468000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	110144000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	518707000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	521997000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	31897000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	0	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	59494000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	68975000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	697566000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1377072000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	128503000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	137898000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	285737000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	404766000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	416753000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	545218000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	373131000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	360025000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	789884000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	905243000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1487450000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2282315000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	288945000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	883001000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	799240000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	148743000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	168957000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	140561000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	151390000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	129259000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	100064000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17280000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18369000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15219000	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-3286000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7800000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	6466000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2021	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2023	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	11249000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	320593000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	308785000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	244595000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-31648000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	574216000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	554645000	usd
CY2023	us-gaap	Interest Expense InterestExpense	45892000	usd
CY2022	us-gaap	Interest Expense InterestExpense	20414000	usd
CY2021	us-gaap	Interest Expense InterestExpense	30260000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	27727000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	2338000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-208000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	-668886000	usd
CY2022	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	4102000	usd
CY2021	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	-6101000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1337000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-358000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	279000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	551472000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	530765000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61515000	usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.67
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131919000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131545000	shares
CY2023	us-gaap	Profit Loss ProfitLoss	-138375000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	490663000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	469250000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	55000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-138375000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	490663000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	469305000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	usd
CY2021	mrvi	Adjustments To Additional Paid In Capital Tax Receivable Agreement Impact AdjustmentsToAdditionalPaidInCapitalTaxReceivableAgreementImpact	53000000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1670000	usd
CY2021	mrvi	Noncontrolling Interest Increase From Cash Distribution Value NoncontrollingInterestIncreaseFromCashDistributionValue	5220000	usd
CY2021	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	0	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10458000	usd
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	153492000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	469250000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	55000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	545361000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2305000	usd
CY2022	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	0	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18670000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	150065000	usd
CY2022	mrvi	Adjustments To Additional Paid In Capital Change In Deferred Tax Asset AdjustmentsToAdditionalPaidInCapitalChangeInDeferredTaxAsset	1691000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	490663000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	905243000	usd
CY2023	mrvi	Effects Of Organizational Transactions Value EffectsOfOrganizationalTransactionsValue	942000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	121000	usd
CY2023	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	0	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	34588000	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	9607000	usd
CY2023	mrvi	Adjustments To Additional Paid In Capital Change In Deferred Tax Asset AdjustmentsToAdditionalPaidInCapitalChangeInDeferredTaxAsset	3028000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-138375000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	789884000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-138375000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	490663000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	469250000	usd
CY2023	us-gaap	Depreciation Depreciation	12898000	usd
CY2022	us-gaap	Depreciation Depreciation	7566000	usd
CY2021	us-gaap	Depreciation Depreciation	6413000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	27356000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	24269000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	18339000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	8527000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	6268000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	8792000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2929000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2788000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2676000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	34588000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	18670000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	10458000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-208000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	754942000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	42318000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	46904000	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-3286000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7800000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	11249000	usd
CY2023	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	668886000	usd
CY2022	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	-4102000	usd
CY2021	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	6101000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2313000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	7993000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	281000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-84395000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	22272000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	70391000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-649000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9459000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	21574000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-8136000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	52873000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9513000	usd
CY2023	mrvi	Increase Decrease In Government Funding Receivable IncreaseDecreaseInGovernmentFundingReceivable	0	usd
CY2022	mrvi	Increase Decrease In Government Funding Receivable IncreaseDecreaseInGovernmentFundingReceivable	-16973000	usd
CY2021	mrvi	Increase Decrease In Government Funding Receivable IncreaseDecreaseInGovernmentFundingReceivable	0	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1578000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	15108000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-7123000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-67851000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	3829000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-4521000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	126224000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	535977000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	368570000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	69622000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	238969000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	65553000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17090000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14850000	usd
CY2023	mrvi	Proceeds From Government Assistance Allocated To Property And Equipment ProceedsFromGovernmentAssistanceAllocatedToPropertyAndEquipment	12865000	usd
CY2022	mrvi	Proceeds From Government Assistance Allocated To Property And Equipment ProceedsFromGovernmentAssistanceAllocatedToPropertyAndEquipment	1105000	usd
CY2021	mrvi	Proceeds From Government Assistance Allocated To Property And Equipment ProceedsFromGovernmentAssistanceAllocatedToPropertyAndEquipment	0	usd
CY2023	mrvi	Finance Lease Prepayments Lease Not Yet Commenced FinanceLeasePrepaymentsLeaseNotYetCommenced	0	usd
CY2022	mrvi	Finance Lease Prepayments Lease Not Yet Commenced FinanceLeasePrepaymentsLeaseNotYetCommenced	13278000	usd
CY2021	mrvi	Finance Lease Prepayments Lease Not Yet Commenced FinanceLeasePrepaymentsLeaseNotYetCommenced	0	usd
CY2023	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	0	usd
CY2022	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	0	usd
CY2021	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	548000	usd
CY2023	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	usd
CY2022	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	620000	usd
CY2021	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	119957000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-122310000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-267612000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	105655000	usd
CY2023	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	9607000	usd
CY2022	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	150206000	usd
CY2021	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	153451000	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	8455000	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5440000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	13895000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6000000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	332000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2023	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	6168000	usd
CY2022	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	0	usd
CY2021	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	0	usd
CY2023	mrvi	Payment Of Acquisition Contingent Consideration Holdback PaymentOfAcquisitionContingentConsiderationHoldback	9706000	usd
CY2022	mrvi	Payment Of Acquisition Contingent Consideration Holdback PaymentOfAcquisitionContingentConsiderationHoldback	0	usd
CY2021	mrvi	Payment Of Acquisition Contingent Consideration Holdback PaymentOfAcquisitionContingentConsiderationHoldback	0	usd
CY2023	mrvi	Share Based Payment Arrangement Value Shares Withheld For Tax Withholding Obligation ShareBasedPaymentArrangementValueSharesWithheldForTaxWithholdingObligation	-20000	usd
CY2022	mrvi	Share Based Payment Arrangement Value Shares Withheld For Tax Withholding Obligation ShareBasedPaymentArrangementValueSharesWithheldForTaxWithholdingObligation	2358000	usd
CY2021	mrvi	Share Based Payment Arrangement Value Shares Withheld For Tax Withholding Obligation ShareBasedPaymentArrangementValueSharesWithheldForTaxWithholdingObligation	1709000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-61090000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-187499000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-159049000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-88000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-57176000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	80866000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	315088000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	632138000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	551272000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	236184000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	574962000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	632138000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	551272000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	44256000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	20198000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	27234000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-2987000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	23032000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	22473000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2011000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1701000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2149000	usd
CY2023	mrvi	Accrued Receivable For Capital Expenditures To Be Reimbursed Under Government Contract AccruedReceivableForCapitalExpendituresToBeReimbursedUnderGovernmentContract	1118000	usd
CY2022	mrvi	Accrued Receivable For Capital Expenditures To Be Reimbursed Under Government Contract AccruedReceivableForCapitalExpendituresToBeReimbursedUnderGovernmentContract	0	usd
CY2021	mrvi	Accrued Receivable For Capital Expenditures To Be Reimbursed Under Government Contract AccruedReceivableForCapitalExpendituresToBeReimbursedUnderGovernmentContract	0	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	32862000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3931000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	17513000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023	mrvi	Noncash Business Combination Contingent Consideration Arrangements Liability NoncashBusinessCombinationContingentConsiderationArrangementsLiability	5289000	usd
CY2022	mrvi	Noncash Business Combination Contingent Consideration Arrangements Liability NoncashBusinessCombinationContingentConsiderationArrangementsLiability	7800000	usd
CY2021	mrvi	Noncash Business Combination Contingent Consideration Arrangements Liability NoncashBusinessCombinationContingentConsiderationArrangementsLiability	0	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	0	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	10000000	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	0	usd
CY2023	mrvi	Conversion Of Stock Deferred Tax Asset ConversionOfStockDeferredTaxAsset	0	usd
CY2022	mrvi	Conversion Of Stock Deferred Tax Asset ConversionOfStockDeferredTaxAsset	0	usd
CY2021	mrvi	Conversion Of Stock Deferred Tax Asset ConversionOfStockDeferredTaxAsset	423361000	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	366179000	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in accordance with GAAP requires the Company to make judgements, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenue and expenses, and related disclosures. These estimates form the basis for judgments the Company makes about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company bases its estimates and judgments on historical experience and on various other assumptions that the Company believes are reasonable under the circumstances. These estimates are based on management’s knowledge about current events and expectations about actions the Company may undertake in the future. Significant estimates include, but are not limited to, the measurement of right-of-use assets and lease liabilities and related incremental borrowing rate, the payable to related parties pursuant to the Tax Receivable Agreement (as defined in Note 14), the realizability of our net deferred tax assets, and valuation of goodwill and intangible assets acquired in business combinations. Actual results could differ materially from those estimates.</span></div>
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5500000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4800000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	288945000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	883001000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	799240000	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	2900000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	2500000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	1300000	usd
CY2023	mrvi	Tax Receivable Agreement Percentage Of Tax Benefits Paid TaxReceivableAgreementPercentageOfTaxBenefitsPaid	0.85
CY2023	mrvi	Tax Receivable Agreement Percentage Of Tax Benefits Unpaid TaxReceivableAgreementPercentageOfTaxBenefitsUnpaid	0.15
CY2023	mrvi	Tax Receivable Agreement Percentage Of Tax Benefits Paid TaxReceivableAgreementPercentageOfTaxBenefitsPaid	0.85
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div>Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. The Company maintains the majority of its cash balances at multiple financial institutions that management believes are of high-credit quality and financially stable. Cash is deposited with major financial institutions in excess of Federal Deposit Insurance Corporation (“FDIC”) insurance limits. The Company believes it is not exposed to significant credit risk due to the financial strength of the depository institutions in which the cash is held. The Company provides credit, in the normal course of business, to international and domestic distributors as well as certain customers, which are geographically dispersed. The Company attempts to limit its credit risk by performing ongoing credit evaluations of its customers and maintaining adequate allowances for potential credit losses.
CY2023	mrvi	Conversion Of Stock Conversion Ratio ConversionOfStockConversionRatio	1
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1400000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2200000	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	700000	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	500000	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	usd
CY2023Q4	us-gaap	Goodwill Goodwill	326000000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	283700000	usd
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	4	reporting_unit
CY2022	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3	reporting_unit
CY2023Q4	us-gaap	Number Of Reporting Units NumberOfReportingUnits	4	reporting_unit
CY2022Q4	us-gaap	Goodwill Goodwill	283668000	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	42361000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	326029000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	349762000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	128775000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	220987000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P8Y8M12D
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	318082000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	101419000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	216663000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P9Y3M18D
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	27478000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	27335000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	27098000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	26082000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	25862000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	87132000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	220987000	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	427244000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7800000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-3286000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2003000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	19338000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	13486000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12680000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	21950000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	19379000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7716000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	51397000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	43152000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	78599000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	0	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	32214000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19502000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	162900000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	52694000	usd
CY2023	us-gaap	Depreciation Depreciation	12900000	usd
CY2022	us-gaap	Depreciation Depreciation	7600000	usd
CY2021	us-gaap	Depreciation Depreciation	6400000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	59746000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	63896000	usd
CY2023Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	8559000	usd
CY2022Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	11362000	usd
CY2023Q4	mrvi	Business Combination Indemnification Assets Carrying Value BusinessCombinationIndemnificationAssetsCarryingValue	6388000	usd
CY2022Q4	mrvi	Business Combination Indemnification Assets Carrying Value BusinessCombinationIndemnificationAssetsCarryingValue	7682000	usd
CY2023Q4	mrvi	Prepaid Lease Payments PrepaidLeasePayments	0	usd
CY2022Q4	mrvi	Prepaid Lease Payments PrepaidLeasePayments	27253000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	2929000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	5396000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	77622000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	115589000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12905000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	19873000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	9202000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	7700000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6780000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6269000	usd
CY2023Q4	mrvi	Accrued Restructuring Costs Current AccruedRestructuringCostsCurrent	2814000	usd
CY2022Q4	mrvi	Accrued Restructuring Costs Current AccruedRestructuringCostsCurrent	0	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2277000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4093000	usd
CY2023Q4	mrvi	Contract With Customer Liability Current Customer Deposits ContractWithCustomerLiabilityCurrentCustomerDeposits	2156000	usd
CY2022Q4	mrvi	Contract With Customer Liability Current Customer Deposits ContractWithCustomerLiabilityCurrentCustomerDeposits	1665000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1001000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1029000	usd
CY2023Q4	mrvi	Inventory Holdback Liability Current InventoryHoldbackLiabilityCurrent	0	usd
CY2022Q4	mrvi	Inventory Holdback Liability Current InventoryHoldbackLiabilityCurrent	10000000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3656000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2742000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60237000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	53371000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6780000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6269000	usd
CY2023Q4	mrvi	Finance And Operating Lease Liability Current FinanceAndOperatingLeaseLiabilityCurrent	7413000	usd
CY2022Q4	mrvi	Finance And Operating Lease Liability Current FinanceAndOperatingLeaseLiabilityCurrent	6269000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	31897000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	0	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	47510000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	51556000	usd
CY2023Q4	mrvi	Finance And Operating Lease Liability Non Current FinanceAndOperatingLeaseLiabilityNonCurrent	79407000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	47510000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	51556000	usd
CY2023Q4	mrvi	Business Combination Tax Liability Noncurrent BusinessCombinationTaxLiabilityNoncurrent	6388000	usd
CY2022Q4	mrvi	Business Combination Tax Liability Noncurrent BusinessCombinationTaxLiabilityNoncurrent	7682000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	1872000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2023Q4	mrvi	Other Liabilities Miscellaneous Noncurrent OtherLiabilitiesMiscellaneousNoncurrent	522000	usd
CY2022Q4	mrvi	Other Liabilities Miscellaneous Noncurrent OtherLiabilitiesMiscellaneousNoncurrent	413000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	59494000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	68975000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	75382000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	0	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	59746000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	63896000	usd
CY2023Q4	mrvi	Finance And Operating Lease Right Of Use Asset FinanceAndOperatingLeaseRightOfUseAsset	135128000	usd
CY2022Q4	mrvi	Finance And Operating Lease Right Of Use Asset FinanceAndOperatingLeaseRightOfUseAsset	63896000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	633000	usd
CY2022Q4	mrvi	Finance And Operating Lease Liability Non Current FinanceAndOperatingLeaseLiabilityNonCurrent	51556000	usd
CY2023	mrvi	Finance Lease Depreciation FinanceLeaseDepreciation	3217000	usd
CY2022	mrvi	Finance Lease Depreciation FinanceLeaseDepreciation	0	usd
CY2021	mrvi	Finance Lease Depreciation FinanceLeaseDepreciation	0	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1696000	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
CY2023	mrvi	Finance Lease Cost FinanceLeaseCost	4913000	usd
CY2022	mrvi	Finance Lease Cost FinanceLeaseCost	0	usd
CY2021	mrvi	Finance Lease Cost FinanceLeaseCost	0	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	12417000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	8800000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	8792000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	3940000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	2742000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	1759000	usd
CY2023	us-gaap	Lease Cost LeaseCost	21270000	usd
CY2022	us-gaap	Lease Cost LeaseCost	11542000	usd
CY2021	us-gaap	Lease Cost LeaseCost	10551000	usd
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P14Y2M12D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y3M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y10M24D
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.084
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.067
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.065
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	332000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	1696000	usd
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	0	usd
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	0	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	10306000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	7049000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	6335000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	32862000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3931000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	17513000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	3327000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	10224000	usd
CY2023Q4	mrvi	Finance Lease And Operating Lease Liability To Be Paid Year One FinanceLeaseAndOperatingLeaseLiabilityToBePaidYearOne	13551000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	3427000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	10392000	usd
CY2023Q4	mrvi	Finance Lease And Operating Lease Liability To Be Paid Year Two FinanceLeaseAndOperatingLeaseLiabilityToBePaidYearTwo	13819000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	3530000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	10039000	usd
CY2023Q4	mrvi	Finance Lease And Operating Lease Liability To Be Paid Year Three FinanceLeaseAndOperatingLeaseLiabilityToBePaidYearThree	13569000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	3636000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	8561000	usd
CY2023Q4	mrvi	Finance Lease And Operating Lease Liability To Be Paid Year Four FinanceLeaseAndOperatingLeaseLiabilityToBePaidYearFour	12197000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	3745000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	8666000	usd
CY2023Q4	mrvi	Finance Lease And Operating Lease Liability To Be Paid Year Five FinanceLeaseAndOperatingLeaseLiabilityToBePaidYearFive	12411000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	40357000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	25432000	usd
CY2023Q4	mrvi	Finance Lease And Operating Lease Liability To Be Paid After Year Five FinanceLeaseAndOperatingLeaseLiabilityToBePaidAfterYearFive	65789000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	58022000	usd
CY2021Q4	mrvi	Noncontrolling Interest Common Units Acquired Price Per Share NoncontrollingInterestCommonUnitsAcquiredPricePerShare	40.25
CY2021Q4	mrvi	Noncontrolling Interest Common Unit Forfeiture Percentage NoncontrollingInterestCommonUnitForfeiturePercentage	0.02036
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	mrvi	Noncontrolling Interest Common Units Acquired NoncontrollingInterestCommonUnitsAcquired	2732919	shares
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	73314000	usd
CY2023Q4	mrvi	Finance Lease And Operating Lease Liability To Be Paid FinanceLeaseAndOperatingLeaseLiabilityToBePaid	131336000	usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	25492000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	19024000	usd
CY2023Q4	mrvi	Finance Lease And Operating Lease Liability Undiscounted Excess Amount FinanceLeaseAndOperatingLeaseLiabilityUndiscountedExcessAmount	44516000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	32530000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	54290000	usd
CY2023Q4	mrvi	Finance Lease And Operating Lease Liability FinanceLeaseAndOperatingLeaseLiability	86820000	usd
CY2023	us-gaap	Unrecorded Unconditional Purchase Obligation Purchases UnrecordedUnconditionalPurchaseObligationPurchases	3000000	usd
CY2021	us-gaap	Unrecorded Unconditional Purchase Obligation Purchases UnrecordedUnconditionalPurchaseObligationPurchases	0	usd
CY2022	us-gaap	Unrecorded Unconditional Purchase Obligation Purchases UnrecordedUnconditionalPurchaseObligationPurchases	0	usd
CY2023Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	3300000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	8973000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	11123000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	524147000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	527437000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5440000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5440000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	518707000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	521997000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5440000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	5440000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	5440000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	516800000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	533120000	usd
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q1	mrvi	Weighted Average Price Period Used For Calculation WeightedAveragePricePeriodUsedForCalculation	P50D
CY2023Q1	mrvi	Noncontrolling Interest Common Unit Forfeiture Percentage NoncontrollingInterestCommonUnitForfeiturePercentage	0.037
CY2023	us-gaap	Profit Loss ProfitLoss	-138375000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	490663000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	469250000	usd
CY2023	mrvi	Net Income Loss Attributable To Common Noncontrolling Interest NetIncomeLossAttributableToCommonNoncontrollingInterest	-19346000	usd
CY2022	mrvi	Net Income Loss Attributable To Common Noncontrolling Interest NetIncomeLossAttributableToCommonNoncontrollingInterest	270458000	usd
CY2021	mrvi	Net Income Loss Attributable To Common Noncontrolling Interest NetIncomeLossAttributableToCommonNoncontrollingInterest	287213000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-119029000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	220205000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	182037000	usd
CY2023	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2022	us-gaap	Dilutive Securities DilutiveSecurities	87000	usd
CY2021	us-gaap	Dilutive Securities DilutiveSecurities	132000	usd
CY2023	mrvi	Dilutive Securities Effect On Basic Earnings Per Share Conversion Of Class B Common Stock DilutiveSecuritiesEffectOnBasicEarningsPerShareConversionOfClassBCommonStock	0	usd
CY2022	mrvi	Dilutive Securities Effect On Basic Earnings Per Share Conversion Of Class B Common Stock DilutiveSecuritiesEffectOnBasicEarningsPerShareConversionOfClassBCommonStock	205984000	usd
CY2021	mrvi	Dilutive Securities Effect On Basic Earnings Per Share Conversion Of Class B Common Stock DilutiveSecuritiesEffectOnBasicEarningsPerShareConversionOfClassBCommonStock	220187000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-119029000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	426276000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	402356000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131919000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131545000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	114791000	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	109000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	153000	shares
CY2023	mrvi	Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Common Stock IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfCommonStock	0	shares
CY2022	mrvi	Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Common Stock IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfCommonStock	123669000	shares
CY2021	mrvi	Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Common Stock IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfCommonStock	142859000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131919000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	255323000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	257803000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.90
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.67
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.59
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.90
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.67
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.56
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	126521000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2856000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	367000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2893000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	26.45
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y10M24D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2270000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	14.76
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	858000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	25.11
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4305000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.55
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	19000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1456000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	24.76
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y8M12D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	11900000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	7700000	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	4300000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	26300000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	39924000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	36564000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	90974000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	2394000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	10340000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	754942000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	42318000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	46904000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	34588000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18670000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10458000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	617681000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	551472000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	530853000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	55000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-88000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	617736000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	551472000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	530765000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	405000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	16312000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	9291000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	756000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2173000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1623000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	8000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	6000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3697000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1169000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	18491000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	14611000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	663968000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	756111000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	60809000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61515000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.149
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.006
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.022
CY2023	mrvi	Effective Income Tax Rate Reconciliation Deferred Tax Revaluation Percent EffectiveIncomeTaxRateReconciliationDeferredTaxRevaluationPercent	0.012
CY2022	mrvi	Effective Income Tax Rate Reconciliation Deferred Tax Revaluation Percent EffectiveIncomeTaxRateReconciliationDeferredTaxRevaluationPercent	0.003
CY2021	mrvi	Effective Income Tax Rate Reconciliation Deferred Tax Revaluation Percent EffectiveIncomeTaxRateReconciliationDeferredTaxRevaluationPercent	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.008
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.103
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.114
CY2023	mrvi	Effective Income Tax Rate Reconciliation Gain On Liquidation Of Subsidiary Percent EffectiveIncomeTaxRateReconciliationGainOnLiquidationOfSubsidiaryPercent	0
CY2022	mrvi	Effective Income Tax Rate Reconciliation Gain On Liquidation Of Subsidiary Percent EffectiveIncomeTaxRateReconciliationGainOnLiquidationOfSubsidiaryPercent	0
CY2021	mrvi	Effective Income Tax Rate Reconciliation Gain On Liquidation Of Subsidiary Percent EffectiveIncomeTaxRateReconciliationGainOnLiquidationOfSubsidiaryPercent	-0.007
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.001
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.004
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.876
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.001
CY2023	mrvi	Effective Income Tax Rate Reconciliation Nondeductible Expense Tax Receivable Agreement Movement Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTaxReceivableAgreementMovementPercent	-0.030
CY2022	mrvi	Effective Income Tax Rate Reconciliation Nondeductible Expense Tax Receivable Agreement Movement Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTaxReceivableAgreementMovementPercent	0
CY2021	mrvi	Effective Income Tax Rate Reconciliation Nondeductible Expense Tax Receivable Agreement Movement Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTaxReceivableAgreementMovementPercent	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.006
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.007
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	1.225
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.110
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.116
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6257000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	241000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	220000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	595796000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	636498000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	40980000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	0	usd
CY2023Q4	mrvi	Deferred Tax Assets Deductions For Tax Receivable Agreement DeferredTaxAssetsDeductionsForTaxReceivableAgreement	1408000	usd
CY2022Q4	mrvi	Deferred Tax Assets Deductions For Tax Receivable Agreement DeferredTaxAssetsDeductionsForTaxReceivableAgreement	148681000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	3256000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	3265000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	712000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1131000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	642152000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	789575000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	642152000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	23776000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	765799000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	3300000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	41000000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	618400000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	700000	usd
CY2023	mrvi	Effective Income Tax Rate Reconciliation Deferred Tax Liability Reversal Amount EffectiveIncomeTaxRateReconciliationDeferredTaxLiabilityReversalAmount	-8800000	usd
CY2023	mrvi	Effective Income Tax Rate Reconciliation Deferred Tax Asset Reversal Amount EffectiveIncomeTaxRateReconciliationDeferredTaxAssetReversalAmount	17100000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	3300000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5200000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6300000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	2600000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	300000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	99000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	130000	usd
CY2023	mrvi	Business Combination Acquisition Related Tax Adjustment BusinessCombinationAcquisitionRelatedTaxAdjustment	-1293000	usd
CY2022	mrvi	Business Combination Acquisition Related Tax Adjustment BusinessCombinationAcquisitionRelatedTaxAdjustment	-349000	usd
CY2021	mrvi	Business Combination Acquisition Related Tax Adjustment BusinessCombinationAcquisitionRelatedTaxAdjustment	0	usd
CY2023	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	668886000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	232000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	6775000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1158000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	889000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	211000	usd
CY2022	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	-4102000	usd
CY2021	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	6101000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5198000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6257000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	241000	usd
CY2023	mrvi	Tax Receivable Agreement Percentage Of Tax Benefits Paid TaxReceivableAgreementPercentageOfTaxBenefitsPaid	0.85
CY2023	mrvi	Tax Receivable Agreement Remaining Percentage TaxReceivableAgreementRemainingPercentage	0.15
CY2023	mrvi	Assumed Effective Income Tax Rate Reconciliation Percent AssumedEffectiveIncomeTaxRateReconciliationPercent	0.467
CY2023	mrvi	Assumed Effective Income Tax Rate Reconciliation Business Income Deduction Unavailable Percent AssumedEffectiveIncomeTaxRateReconciliationBusinessIncomeDeductionUnavailablePercent	0.541
CY2023Q4	mrvi	Tax Distribution Payable TaxDistributionPayable	0	usd
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2100000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1600000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1300000	usd
CY2023	mrvi	Conversion Of Stock Conversion Ratio ConversionOfStockConversionRatio	1
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	288945000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	883001000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	799240000	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	27356000	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	24269000	usd
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	18339000	usd
CY2023	us-gaap	Depreciation Depreciation	12898000	usd
CY2022	us-gaap	Depreciation Depreciation	7566000	usd
CY2021	us-gaap	Depreciation Depreciation	6413000	usd
CY2023	us-gaap	Interest Expense InterestExpense	45892000	usd
CY2022	us-gaap	Interest Expense InterestExpense	20414000	usd
CY2021	us-gaap	Interest Expense InterestExpense	30260000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	27727000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	2338000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	usd
CY2023	mrvi	Corporate Costs Net Of Eliminations CorporateCostsNetOfEliminations	64257000	usd
CY2022	mrvi	Corporate Costs Net Of Eliminations CorporateCostsNetOfEliminations	55378000	usd
CY2021	mrvi	Corporate Costs Net Of Eliminations CorporateCostsNetOfEliminations	43265000	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-3286000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7800000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	12695000	usd
CY2022	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	13362000	usd
CY2021	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	44000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	34588000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18670000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10458000	usd
CY2023	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	11249000	usd
CY2023	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	4392000	usd
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2416000	usd
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1508000	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	0	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	1078000	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	2383000	usd
CY2023	mrvi	Ceo Transition Costs CEOTransitionCosts	-28000	usd
CY2022	mrvi	Ceo Transition Costs CEOTransitionCosts	-2426000	usd
CY2021	mrvi	Ceo Transition Costs CEOTransitionCosts	0	usd
CY2023	us-gaap	Restructuring Costs RestructuringCosts	6567000	usd
CY2022	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2021	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2023	us-gaap	Other Adjustments To Income Discontinued Operations OtherAdjustmentsToIncomeDiscontinuedOperations	-1763000	usd
CY2022	us-gaap	Other Adjustments To Income Discontinued Operations OtherAdjustmentsToIncomeDiscontinuedOperations	-1814000	usd
CY2021	us-gaap	Other Adjustments To Income Discontinued Operations OtherAdjustmentsToIncomeDiscontinuedOperations	0	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	617736000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	551472000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	530765000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	756111000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	60809000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61515000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-138375000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	490663000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	469250000	usd
CY2023	mrvi	Restructuring Costs Included In Share Based Payment Arrangement Expense RestructuringCostsIncludedInShareBasedPaymentArrangementExpense	100000	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001823239-24-000032-index-headers.html	Edgar Link	pending
0001823239-24-000032-index.html	Edgar Link	pending
0001823239-24-000032.txt	Edgar Link	pending
0001823239-24-000032-xbrl.zip	Edgar Link	pending
a10-kex1015xflanderslease.htm	Edgar Link	pending
a10-kex1018xcygnuslease.htm	Edgar Link	pending
a10-kex971xclawbackpolicy.htm	Edgar Link	pending
aex1016xflandersleaseamend.htm	Edgar Link	pending
aex1017xflandersleaseamend.htm	Edgar Link	pending
aex1021xfirstamendmenttocr.htm	Edgar Link	pending
aex1024xamendmentno1toarem.htm	Edgar Link	pending
aex1033xformofoptionagreem.htm	Edgar Link	pending
aex1034xformofrsuagreement.htm	Edgar Link	pending
aex1035xformofpsuagreement.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
image_1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mrvi-20231231.htm	Edgar Link	pending
mrvi-20231231.xsd	Edgar Link	pending
mrvi-20231231_g1.jpg	Edgar Link	pending
mrvi-20231231_g2.jpg	Edgar Link	pending
mrvi-20231231_g3.jpg	Edgar Link	pending
mrvi-20231231_g4.jpg	Edgar Link	pending
mrvi-20231231_g5.jpg	Edgar Link	pending
mrvi-20231231_g6.jpg	Edgar Link	pending
mrvi-20231231_g7.jpg	Edgar Link	pending
mrvi-2023form10xkxex211xli.htm	Edgar Link	pending
mrvi-2023form10xkxex231xco.htm	Edgar Link	pending
mrvi-2023form10xkxex311xce.htm	Edgar Link	pending
mrvi-2023form10xkxex321xce.htm	Edgar Link	pending
mrvi-2023form10xkxex322xcf.htm	Edgar Link	pending
mrvi-2023form10xkxex42xdes.htm	Edgar Link	pending
mrvi-form202310xkxex312xcf.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
mrvi-20231231_cal.xml	Edgar Link	unprocessable
mrvi-20231231_def.xml	Edgar Link	unprocessable
mrvi-20231231_lab.xml	Edgar Link	unprocessable
mrvi-20231231_pre.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mrvi-20231231_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock $mrvi

2023 Q4 Form 10-K Financial Statement

#000182323924000032 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. Stock $mrvi

2023 Q4 Form 10-K Financial Statement

#000182323924000032 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock $mrvi